Detalhe da pesquisa
1.
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.
Clin Infect Dis
; 78(2): 338-348, 2024 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37633258
2.
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
N Engl J Med
; 385(15): 1355-1371, 2021 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34496194
3.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
MMWR Morb Mortal Wkly Rep
; 73(12): 271-276, 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38547037
4.
Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022.
J Infect Dis
; 227(8): 961-969, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36415904
5.
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
J Infect Dis
; 227(12): 1348-1363, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36806690
6.
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
Clin Infect Dis
; 76(9): 1615-1625, 2023 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36611252
7.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
MMWR Morb Mortal Wkly Rep
; 72(21): 579-588, 2023 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37227984
8.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36264840
9.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 139-145, 2022 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35085224
10.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep
; 71(13): 495-502, 2022 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35358170
11.
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 255-263, 2022 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35176007
12.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 352-358, 2022 Mar 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35239634
13.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep
; 71(29): 931-939, 2022 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35862287
14.
Mitigation of COVID-19 at the 2021 National Collegiate Athletic Association Men's Basketball Tournament.
BMC Public Health
; 22(1): 2061, 2022 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36357870
15.
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1539-1544, 2021 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34735425
16.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1553-1559, 2021 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34735426
17.
Mobility Impairment in Patients New to Dialysis.
Am J Nephrol
; 51(9): 705-714, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32781443
18.
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.
MMWR Morb Mortal Wkly Rep
; 69(29): 960-964, 2020 07 24.
Artigo
Inglês
| MEDLINE | ID: mdl-32701938
19.
Use of Functional Linear Models to Detect Associations between Characteristics of Walking and Continuous Responses Using Accelerometry Data.
Sensors (Basel)
; 20(21)2020 Nov 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33182460
20.
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
Am J Transplant
; 23(7): 1062-1076, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37394267